Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Reuters Health News

The Food and Drug Administration approved a two-in-one Type-2 Diabetes pill from AstraZeneca, reports Reuters. The pill contains Xigduo XR, a combination of dapagliflozin and metformin hydrochloride, which removes glucose from the body. Xigduo XR is the...
We may be one step closer to obtaining an Ebola vaccine, Reuters reports. A 5 million dollar grant was given in order to allow trials of an experimental vaccine, called rVSV-EBOV, developed by the Canadian government and licensed to NewLink Genetics, in...
NEW YORK (Reuters Health) – The extent of resection and residual volume are independently tied to survival and recurrence after surgery for newly diagnosed glioblastoma, according to a retrospective study. Gross total resection is associated with...